S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:GRPH

Graphite Bio (GRPH) Stock Price, News & Analysis

$3.18
-0.09 (-2.75%)
(As of 03/21/2024)
Today's Range
$3.05
$3.23
50-Day Range
$3.18
$26.11
52-Week Range
$2.01
$4.26
Volume
328,300 shs
Average Volume
282,405 shs
Market Capitalization
$185.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRPH stock logo

About Graphite Bio Stock (NASDAQ:GRPH)

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.

GRPH Stock Price History

GRPH Stock News Headlines

GRPH Mar 2024 5.000 put
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
VERI, STI and VERB among mid-day movers
GRPH Mar 2024 7.500 call
Graphite Bio, Inc. (GRPH)
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
What Makes Graphite Bio, Inc. (GRPH) a New Buy Stock
Graphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-market
Graphite Bio Inc GRPH
See More Headlines
Receive GRPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/20/2023
Ex-Dividend for 3/21 Dividend
3/15/2024
Dividend Payable
3/21/2024
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRPH
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-124,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.15 per share

Miscellaneous

Free Float
35,874,000
Market Cap
$185.20 million
Optionable
Not Optionable
Beta
0.20
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

GRPH Stock Analysis - Frequently Asked Questions

How have GRPH shares performed in 2024?

Graphite Bio's stock was trading at $18.34 at the start of the year. Since then, GRPH stock has decreased by 82.7% and is now trading at $3.18.
View the best growth stocks for 2024 here
.

How were Graphite Bio's earnings last quarter?

Graphite Bio, Inc. (NASDAQ:GRPH) issued its quarterly earnings data on Monday, March, 20th. The company reported ($3.08) earnings per share for the quarter, beating the consensus estimate of ($3.43) by $0.35.

How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio?

Graphite Bio announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be paid a dividend of $7.21 per share on Thursday, March 21st. This represents a dividend yield of 28.93%. The ex-dividend date is Friday, March 15th.
Read our dividend analysis for GRPH
.

When did Graphite Bio's stock split?

Shares of Graphite Bio reverse split on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did Graphite Bio IPO?

Graphite Bio (GRPH) raised $224 million in an IPO on Friday, June 25th 2021. The company issued 14,000,000 shares at $15.00-$17.00 per share.

Who are Graphite Bio's major shareholders?

Graphite Bio's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.46%), Vanguard Group Inc. (2.45%), Nantahala Capital Management LLC (1.42%), BML Capital Management LLC (0.77%), BML Capital Management LLC (0.77%) and Sectoral Asset Management Inc. (0.76%). Insiders that own company stock include Biocapital LP Samsara and Phil Gutry.
View institutional ownership trends
.

How do I buy shares of Graphite Bio?

Shares of GRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRPH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners